Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Free-living Ageing Study (BELFAST)

https://doi.org/10.1016/S0047-6374(01)00278-0Get rights and content

Abstract

The ApoE gene has three alleles coding for the proteins apoE2, apoE3 and apoE4. E4 has been reported to be associated with hypercholesteraemia, ischaemic heart disease, age-related cognitive decline and Alzheimer's disease. Conversely, the E2 allele has been associated with longevity in French centenarians and their siblings. In this study, we have assessed any shift in the ApoE genotypes in nonagenarian subjects from Belfast where there is a high intrinsic incidence of cardiovascular disease. ApoE phenotypes were determined by electrofocusing and immunoblotting in 114 Senieur-approximated subjects >90 years old and compared with 2071 subjects, 30–65 years of age, recruited from the same geographical area by the MONItoring of CArdiovascular trends study group in Belfast (MONICA). The E4 allele was reduced in the nonagenarian group (X2=11.1; P=0.0006), the E3 unchanged and E2 frequency was increased (X2=4.0; P=0.047). These results suggest that longevity is negatively associated with the E4 allele and may be associated with carriage of E2.

Introduction

Many studies have demonstrated the importance of the ApoE gene in cholesterol metabolism (Utermann, 1987, Xhignesse et al., 1991). The three main alleles of the gene E2, E3 and E4, which differ on the basis of two amino acids, appear to have different thresholds for solubility and association characteristics for their ligands, the ApoE and the low density lipoprotein receptors on liver cell plasma membranes. ApoE2 has markedly lower binding affinity to receptors compared with apoE3 and E4 isoforms and this may be the basis for the finding that E4 phenotypes tend to have higher cholesterol and for apoE-related disease associations (Utermann, 1987, Smith, 2000). Many studies have shown an association between ApoE genotype and ischaemic heart disease, with carriage of the E4 allele being associated with higher cholesterol and cardiovascular risk, compared with E3 and E2 alleles (Nassar et al., 1999, Alafuzoff et al., 2000). However, this is not invariably so since the Sudanese population have not only the highest allelic frequency of E4 (29%), described in any population group, but coronary heart disease is almost unkonwn (Hallman et al., 1991). Similarly, there has been a flurry of studies not only demonstrating a clear relationship between apoE4 and Alzheimer's disease (Farrer et al., 1997) but with age-related cognitive decline (Henderson et al., 1999, Haan et al., 1999, O'Hara et al., 1998). These findings suggest that carriage of apoE alleles, particularly E4, may be associated with a reduced survivor profile.

Since, elderly people are survivors of their peer groups and seem likely to have been protected from premature vascular disease and its associated mortality, it might be predicted that there would be an under-representation of the E4 alleles in healthy very elderly people. In keeping with this hypothesis, several studies have demonstrated a decline in the E4 allele in very elderly subjects in Caucasian population groups (Eggertsen et al., 1993, Louhija et al., 1994, Rulu et al., 1995, Kervinen et al., 1994, Galinsky et al., 1997, Jian-Gang et al., 1998) though some studies did not (Bladbjerg et al., 1999). An interesting report by Schachter et al., 1994 not only substantiated this hypothesis but in addition demonstrated an association between the E2 allele and longevity in French centenarians and their siblings. In addition, reports also suggested that apoE2 might be protective against Alzheimers disease (Corder et al., 1994). We were interested to carry out a similar study in Northern Ireland, which has not only one of the highest incidences of heart disease in the world (Tunstall-Pedoe et al., 1994), but a relatively stable Caucasian gene pool which could enhance the possibility of identifying important ‘survivor’ or longevity genes.

Section snippets

MONICA subjects

Subjects in the 25–64 year age group were enlisted from the Greater Belfast area (target population 250 000) with the help of General Practitioners. This group has been earlier described (Tunstall-Pedoe et al., 1994) and formed part of the World Health Organisation's Belfast project, MONItoring of trends and determinants in CArdiovascular disease project (MONICA).

Nonagenarian subjects. As part of the Belfast Elderly Longitudinal Free-living Ageing STudy (BELFAST) ongoing study in ageing,

Results

The results show a shift in the apoE phenotypes in the >90 year old group compared with younger subjects in the MONICA group (Table 1) with a significant decrease in the E4 allele in nonagenarians (7.5%) compared with the MONICA study group (15.9%). Conversely, there was an increase in the E2 allele in nonagenarians (12.2%) compared with the MONICA group (8.3%), which just achieved significance. There was no difference in the frequency of the E3 allele between the 2 groups (80 vs. 76%).

Discussion

These results are of interest because they suggest that subjects carrying the E4 allele may be less likely to survive into very old age. Conversely, nonagenarians carrying the E2 allele have an increased likelihood of good quality survival, at least in Northern Ireland.

Although the results are based on observational evidence, these findings fit with the hypothesis that carriage of the E4 allele may predispose to atherosclerosis and/or Alzheimer's disease thus reducing the chance of survival to

References (25)

  • L.A Farrer et al.

    Effects of age sex and ethnicity on the association between apolipoprotein E genotype and Alzheimers disease

    J. Am. Med. Assoc.

    (1997)
  • M.N Haan et al.

    The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons

    J. Am. Med. Assoc.

    (1999)
  • Cited by (42)

    • Review and meta-analysis of genetic polymorphisms associated with exceptional human longevity

      2018, Mechanisms of Ageing and Development
      Citation Excerpt :

      Details of the gene structure, genomic location and expression across a range of tissues is presented in the Supplementary. A total of 12 studies were included in the APOE ε2/ε3/ε4 meta-analyses comprising 3229 cases and 13685 controls (Blanche et al., 2001; Choi et al., 2003; Feng et al., 2011; Garatachea et al., 2015; Geesaman et al., 2003; Gerdes et al., 2000; Louhija et al., 1994; Present Study, 2017; Rea et al., 2001; Schachter et al., 1994; Zubenko et al., 2002) (Table S2). There was no evidence of winner’s curse phenomenon.

    • Cognitive status in the oldest old and centenarians: a condition crucial for quality of life methodologically difficult to assess

      2017, Mechanisms of Ageing and Development
      Citation Excerpt :

      APOE gene has two common missense variants, rs429358 (Cys130Arg) and rs7412 (Arg176Cys), and the combination of the two determines functional alleles: ε2 (Cys130, Cys176), ε3 (Cys130, Arg176) and ε4 (Arg130, Arg176). APOE is particularly interesting because these variants are associated with age-related diseases, particularly AD (for Italy see: Santoro et al., 2010; Lescai et al., 2011), but also CVD (Rea et al., 2001; Christensen et al., 2006; Yashin et al., 2016). The scenario is also more intriguing as it has been found that APOE variants which confer a higher risk for AD and CVD can exert protective effects against other age-related pathologies such as cancer (Kulminski et al., 2015).

    • The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE e2

      2013, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Mortality in ɛ2 carriers is half, and in ɛ4 carriers twice that in ɛ3 homozygotes (Corder et al., 1996) and ɛ2 carriers are four times as likely as ɛ4 carriers to become centenarians (Schachter et al., 1994). Studies that have compared APOE allele frequencies in age-stratified groups have consistently reported a significantly higher frequency of the ɛ2 allele in elderly individuals and centenarians than in younger populations, and this marked increase in allele frequency has been reported in several different ethnicities (Cauley et al., 1993; Corder et al., 1996; Frisoni et al., 2001; Louhija et al., 1994; Rea et al., 2001). For example, Schachter and colleagues report significant increases in ɛ2 allele frequency from 6.8% in young adults (aged 20–70 years) to 12.8% in centenarians, whereas the ɛ4 allele frequency decreases from 11.2% to 5.2% in the same groups (Schachter et al., 1994).

    • Apolipoprotein E genotypes and the risk of Parkinson disease

      2011, Neurobiology of Aging
      Citation Excerpt :

      It is well-known that ApoE ε4 is a major genetic risk factor for late onset sporadic AD (Farrer et al., 1997), and has also been associated with poor clinical outcome in patients with acute head trauma and stroke (Nicoll et al., 1996; Slooter et al., 1997). On the other hand, the ApoE ε2 allele was associated with lower risk for AD (Farrer et al., 1997) and is overrepresented among centenarians (Rea et al., 2001; Schächter et al., 1994). The hypothesis that ApoE ε4 also increases PD risk has been investigated in over 30 epidemiological studies (www.PDgene.org) with inconsistent results.

    • Apolipoprotein E polymorphism, age and coronary heart disease

      2007, Ageing Research Reviews
      Citation Excerpt :

      On the other hand, the apo ɛ2 allele has been negatively associated with myocardial infarction (Kolovou et al., 2002). Additionally, the ɛ2 allele has been associated with longevity in French centenarians and their siblings (Bailleul et al., 1993) as well as in the cohort of Belfast Elderly Longitudinal Free-living Study (Rea et al., 2001). A Swedish twin study concluded that at younger ages, death from CHD is influenced by genetic factors, while the genetic effect decreases at older ages where environmental factors may play a more prominent role (Marenberg et al., 1994; Zdravkovic et al., 2002).

    View all citing articles on Scopus
    View full text